arrow
S

Sung-Eun Lee

Catholic University of Korea
H指数:31
被引数:4,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Establishing consensus-based recommendations on first-line ruxolitinib failure and transition for myelofibrosis in Korea: A modified Delphi study

基于共识的关于韩国骨髓纤维化患者初始鲁索利替尼治疗失败及转换治疗的推荐意见制定:一项改良德尔菲研究

2026-10-260
PRE
Prognostic value of early lymphocyte dynamics during blinatumomab therapy in relapsed or refractory B-cell precursor acute lymphoblastic leukemia: A real-world retrospective study

在复发或难治性B细胞前体急性淋巴细胞白血病中,使用blinatumomab治疗期间早期淋巴细胞动态变化的预后价值:一项真实世界回顾性研究

2026-09-070
PRE
Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b

中性粒细胞与淋巴细胞比值减半作为接受罗培干扰素alfa-2b治疗的真性红细胞增多症患者分子应答的替代指标

2026-03-300
OA
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study

罗培干扰素alfa-2b在羟基脲不耐受或羟基脲难治性原发性血小板增多症(SURPASS ET):一项多中心、开放标签、随机、活性对照、III期研究

2025-11-030
PRE
BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation

BCR::ABL1阳性的急性淋巴细胞白血病是异基因造血细胞移植后中枢神经系统复发的危险因素。

2025-10-060
OA
A phase I/IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis

PXS-5505(一种新型泛赖氨酰氧化酶抑制剂)在晚期骨髓纤维化中的I/IIa期临床试验

2025-10-010
OAAI
Ponatinib Monotherapy in Adult Patients with Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: A Real-World Retrospective Analysis Including Measurable Residual Disease Relapse

波纳替尼单药治疗成人复发性或难治性费城染色体阳性急性淋巴细胞白血病的真实世界回顾性分析:包括可测量微小残留病复发情况

2025-10-010
OAAI
Outcome of second allogeneic hematopoietic cell transplantation in adult patients with relapsed B-cell acute lymphoblastic leukemia in the era of new immunotherapeutic agents

成人复发B细胞急性淋巴细胞白血病患者在新免疫治疗药物时代的第二次异基因造血细胞移植结局

2025-06-170
PRE
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Pelabresib联合ruxolitinib治疗JAK抑制剂初治骨髓纤维化:一项随机III期试验

2025-03-102
OA